<DOC>
	<DOCNO>NCT00410228</DOCNO>
	<brief_summary>This study evaluate safety tolerability ascend single oral dos AHT956 healthy subject</brief_summary>
	<brief_title>Study Explore Safety , Tolerability , Pharmacokinetics Pharmacodynamics Oral AHT956 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject age 18 45 year age include , good health determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen . Vital sign must within follow range : oral body temperature 35.037.5 °C ; systolic blood pressure , 90145 mm Hg ; diastolic blood pressure , 5095 mm Hg ; pulse rate , 4090 bpm Female subject must either : surgically sterilize hysterectomized last 6 month prior study participation clinical documentation postmenopausal ( regular menstrual bleeding least 1 year prior study start ) Body mass index must within range 18 28 kg/m² . Subjects must weigh least 50 kg participate study . Smokers ( subject use tobacco cotinine great 500 ng/mL ) ) . Subjects received live vaccine 4 week prior dose , prescription drug use 4 week prior dose , overthecounter medication use within 2 week prior dose . Participation clinical investigation within 4 week prior dose longer required local regulation , limitation participation base local regulation . Donation loss 400 mL blood within 8 week prior first dose , longer required local regulation . Flulike symptoms significant within two week prior dose . A past medical history clinically significant abnormality detect electrocardiogram ( ECG ) examination evident family history ( grandparent , parent sibling ) ECG abnormality ( i.e . prolonged QTinterval syndrome ) . History fainting , hypotension standing , arrhythmia . History acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease ( include asthma chronic obstructive pulmonary disease , treat treat ) . History clinically significant drug allergy history atopic allergy , urticaria , eczematous dermatitis ) . A known hypersensitivity study drug drug similar study drug . Any history surgical medical condition ( ) could change absorption , distribution , metabolism excretion drug may jeopardize subject , include history gastrointestinal , pancreatic , liver , kidney , bladder , blood , immune system . History drug alcohol abuse within 12 month prior dose evidence abuse indicate laboratory assay conduct screen baseline evaluation . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>safety , tolerability , pharmacokinetics , pharmacodynamics , AHT956</keyword>
</DOC>